Target intelligence / Profile preview

Daboia siamensis venom metalloproteinase (DsSVMP)

Target
DsSVMP
Molecular classification
Enzyme, Metalloproteinase, Zinc-dependent endopeptidase, Snake venom metalloproteinase (SVMP)
01

Overview

Daboia siamensis venom metalloproteinases (DsSVMPs) are a diverse group of zinc-dependent enzymes that constitute a major toxic component of the Eastern Russell's viper venom (UniProt, 2023). These enzymes are classified into different groups, primarily P-I and P-III, based on their domain structure, which includes metalloproteinase, disintegrin-like, and cysteine-rich domains (PubMed, PMID: 28235531). Their primary biological role in envenomation is the degradation of the extracellular matrix, specifically targeting the basement membrane of vascular endothelial cells, which results in profuse local and systemic hemorrhage (PubMed, PMID: 30145355). Furthermore, certain DsSVMPs act as potent procoagulants by activating Factor X or prothrombin, leading to venom-induced consumption coagulopathy (VICC) and potentially fatal bleeding (NIH, 2022). In the context of drug development, DsSVMPs are targeted by small-molecule inhibitors such as batimastat and marimastat, which bind the catalytic zinc ion, as well as metal chelators like unithiol (DMPS) (PubMed, PMID: 32824330). These therapeutic strategies aim to supplement traditional antivenom therapy, which can sometimes struggle to neutralize the rapid tissue-damaging effects of these enzymes.

Other names
Eastern Russell's viper venom metalloproteinaseDaboia siamensis SVMPRussell's viper venom metalloproteinaseZinc-dependent venom endopeptidase
02

Mechanism of action

Inhibition of enzymatic activity through zinc ion chelation at the catalytic site or competitive inhibition of the substrate-binding pocket.

03

Biological functions

ProteolysisHemorrhage inductionProthrombin activationExtracellular matrix degradationPlatelet aggregation inhibition
04

Disease associations

Snakebite envenomationHemorrhageCoagulopathyTissue necrosisAcute kidney injury
05

Safety considerations

Off-target inhibition of human matrix metalloproteinases (MMPs)Systemic toxicity of metal chelating agentsHypersensitivity or anaphylactic reactions to equine-derived antivenomsRapid onset of local tissue damage potentially outpacing systemic drug distribution
06

Interacting drugs

Batimastat

6 more in the full profile.

07

Biomarkers

Prothrombin time (PT)International Normalized Ratio (INR)Fibrinogen levelD-dimerCreatine kinase (CK)

Beyond the preview

Go deeper on Daboia siamensis venom metalloproteinase (DsSVMP).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Daboia siamensis venom metalloproteinase (DsSVMP).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call